Beinfeld M - Search Results

1

The effectiveness and value of nadofaragene firadenovec, oportuzumab monatox, and pembrolizumab for BCG-unresponsive non-muscle-invasive bladder cancer.

Beinfeld M, Atlas SJ, Touchette D, McKenna A, Rind D, Pearson SD. Beinfeld M, et al. J Manag Care Spec Pharm. 2021 Jun;27(6):797-804. doi: 10.18553/jmcp.2021.27.6.797. J Manag Care Spec Pharm. 2021. PMID: 34057394 Free PMC article.

2

Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma.

Beinfeld M, Lee S, McQueen B, Fluetsch N, Pearson SD, Ollendorf DA. Beinfeld M, et al. J Manag Care Spec Pharm. 2021 Sep;27(9):1315-1320. doi: 10.18553/jmcp.2021.27.9.1315. J Manag Care Spec Pharm. 2021. PMID: 34464215 Free PMC article.

3

Mavacamten for hypertrophic cardiomyopathy: effectiveness and value.

Beinfeld M, Wasfy JH, Walton S, Sarker J, Nhan E, Rind DM, Pearson SD. Beinfeld M, et al. J Manag Care Spec Pharm. 2022 Mar;28(3):369-375. doi: 10.18553/jmcp.2022.28.3.369. J Manag Care Spec Pharm. 2022. PMID: 35199575 Free PMC article.

4

Oral treatments for outpatient COVID-19: Effectiveness and value.

Beinfeld M, Yeung K, Whittington MD, Mohammed R, Nhan E, Pearson SD. Beinfeld M, et al. J Manag Care Spec Pharm. 2022 Aug;28(8):903-909. doi: 10.18553/jmcp.2022.28.8.903. J Manag Care Spec Pharm. 2022. PMID: 35876296 Free PMC article.

5

Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non-Muscle Invasive Bladder Cancer.

Joshi M, Atlas SJ, Beinfeld M, Chapman RH, Rind DM, Pearson SD, Touchette DR. Joshi M, et al. Among authors: beinfeld m. Value Health. 2023 Jun;26(6):823-832. doi: 10.1016/j.jval.2022.12.005. Epub 2022 Dec 16. Value Health. 2023. PMID: 36529422 Free article.

6

Cost-effectiveness of whole-body CT screening.

Beinfeld MT, Wittenberg E, Gazelle GS. Beinfeld MT, et al. Radiology. 2005 Feb;234(2):415-22. doi: 10.1148/radiol.2342032061. Radiology. 2005. PMID: 15670999

7

Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids.

Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS. Beinfeld MT, et al. Radiology. 2004 Jan;230(1):207-13. doi: 10.1148/radiol.2301021482. Radiology. 2004. PMID: 14695395 Review.

8

Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.

Gazelle GS, McMahon PM, Siebert U, Beinfeld MT. Gazelle GS, et al. Among authors: beinfeld mt. Radiology. 2005 May;235(2):361-70. doi: 10.1148/radiol.2352040330. Radiology. 2005. PMID: 15858079 Review.

9

Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.

Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC. Gazelle GS, et al. Among authors: beinfeld m. Ann Surg. 2003 Apr;237(4):544-55. doi: 10.1097/01.SLA.0000059989.55280.33. Ann Surg. 2003. PMID: 12677152 Free PMC article. Review.

10

Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.

Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Gazelle GS, et al. Among authors: beinfeld mt. Radiology. 2004 Dec;233(3):729-39. doi: 10.1148/radiol.2333032052. Radiology. 2004. PMID: 15564408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters